Billionaire investor Ken Fisher has identified Stryker Corporation (NYSE: SYK) as a top healthcare stock in his portfolio, citing significant potential for growth. Fisher Asset Management's investment in Stryker reached approximately $1.17 billion by the end of Q2 2023, underscoring the health care company's importance within his investment strategy.
Stryker has shown robust financial performance, with its Q2 2023 revenues hitting $5 billion and a non-GAAP earnings per share (EPS) of $2.54. These figures surpassed analyst expectations by $170 million and $0.16, respectively, highlighting the company's ability to exceed market forecasts. According to Insider Monkey, the number of hedge funds holding Stryker shares grew from 42 to 46 by the end of Q2 2023, illustrating increased interest from the institutional investor community.
Stryker Corporation, known for its specialization in medical equipment such as spinal implants and knee replacements, operates through its MedSurg and Neurotechnology, and Orthopaedics and Spine segments. As of April 26, 2025, Stryker stocks traded at $365.06, a 1.12% rise from the previous close, reflecting positive market sentiment. The company's strong financials and the backing of influential investors like Ken Fisher signal its ongoing commitment to growth in the healthcare sector.